| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 0.0007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.094 | 0.1 |